Treatment of Fibromyalgia and CFS With Ribose, Ashwagandha, Rhodiola, Licorice, Schisandra and Green Tea Extract
1 other identifier
interventional
70
1 country
1
Brief Summary
Is a combination of Ribose, Ashwagandha, Rhodiola, Schisandra, licorice, and green tea extract helpful in CFS and FIbromyalgia?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Oct 2020
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 14, 2020
CompletedFirst Submitted
Initial submission to the registry
October 15, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 4, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 4, 2021
CompletedOctober 22, 2020
October 1, 2020
9 months
October 15, 2020
October 20, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
VAS
A composite VAS of Fatigue, Pain, Sleep, Cognition and overall well-being. These are each on a 1-10 scale with the same units, with 10 being healthy. The composite sum total of all of these (0-50) will be used as a single outcome measure
4-6 weeks
Study Arms (1)
Treatment of CFS/FMS with the nutritional combination
EXPERIMENTALInterventions
A nutritional /herbal combination
Eligibility Criteria
You may qualify if:
- be diagnosed with CFS and/or fibromyalgia
- live in the United States 3 - be over 18 years of age
You may not qualify if:
- pregnancy
- Diabetes
- Hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kona Research Center
Kailua, Hawaii, 96740, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2020
First Posted
October 22, 2020
Study Start
October 14, 2020
Primary Completion
July 4, 2021
Study Completion
July 4, 2021
Last Updated
October 22, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share